Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
PBM Reform
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Blog
Commitment to Quality
Press Releases
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
PBM Reform
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Blog
Commitment to Quality
Press Releases
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
September 21, 2021
Founders Series
Thank you, Kanu Patel
Blog
September 2, 2021
AAM
Member Spotlight: Zydus USA
Blog
August 27, 2021
AAM
Our Team
Blog
July 19, 2021
AAM
Seniors Are Still Missing Out on Savings in Medicare Part D
Blog
July 7, 2021
AAM
Introducing the AAM All Access Podcast
Blog
July 6, 2021
AAM
A New Resource Showcases Patient Stories. Are You Up Next?
Blog
July 1, 2021
Founders Series
Thank you, Eli Hurvitz
Blog
June 21, 2021
AAM
Member Spotlight: Aurobindo Pharma
Blog
June 16, 2021
AAM
Generic Medicines Provide Savings for Maine Patients
Blog
June 11, 2021
AAM
Access! 2021 Recap: Day Two
Blog
June 7, 2021
AAM
A Respectful Style: WIHP’s Fireside Chat with Representative Ann McLane Kuster
Blog
June 3, 2021
AAM
Access! 2021 Recap: Day One
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
PBM Reform
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Blog
Commitment to Quality
Press Releases
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
